A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

by | Aug 17, 2026 | Clinical Trials | 0 comments

​ Conditions: Generalized Anxiety Disorder

Interventions: Drug: SEP-363856; Drug: Placebo

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.

Recruiting Conditions: Generalized Anxiety Disorder
Interventions: Drug: SEP-363856; Drug: Placebo
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *